Funding Announcements and Opportunities

Funding Announcements

November 2, 2018
Notice of Intent to Publish a FOA for Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)
Estimated Publication Date of FOA: December 08, 2018

November 2, 2018
Notice of Intent to Publish a FOA for Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults (UG3/UH3, Clinical Trial Required)
Estimated Publication Date of FOA: December 08, 2018

November 2, 2018
Notice of Intent to Publish a FOA for Behavioral Research to Improve MAT: Behavioral and Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R61/R33, Clinical Trials Optional)
Estimated Publication Date of FOA: December 08, 2018

November 2, 2018
Notice of Intent to Publish a FOA for Limited Competition: Behavioral Research to Improve MAT: Ancillary Studies to Enhance Behavioral or Social Interventions to Improve Adherence to Medication Assisted Treatment for OUD (R01)
Estimated Publication Date of FOA: December 08, 2018

October 29, 2018
Notice of Intent to Publish for Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trials Required)
Estimated Publication Date of FOA: December 18, 2018

October 23, 2018
Notice of Intent to Publish a FOA for Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
Estimated Publication Date of FOA: November 15, 2018

October 22, 2018
Notice of Intent to Publish a FOA for Translational Devices to Treat Pain (U44 Clinical Trial Optional)
Estimated Publication Date of FOA: November 15, 2018

October 22, 2018
Notice of Intent to Publish a FOA for Development of Translational Devices to Treat Pain (U18 Clinical Trial Not Allowed)
Estimated Publication Date of FOA: December 15, 2018

October 17, 2018
Notice of Intent to Publish a FOA for Clinical Research on Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) - (U01 Clinical Trial Optional)
Estimated Publication Date of FOA: November 21, 2018

October 17, 2018
Notice of Intent to Publish a FOA for Basic Research on Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed)
Estimated Publication Date of FOA: November 21, 2018

October 9, 2018
Notice of Intent to Publish a FOA for the Back Pain Consortium (BACPAC) Research Program: Mechanistic Research Centers (U19) (Clinical Trial Optional) (NOT-AR-19-022)
Estimated Publication Date of FOA: November 21, 2018

October 9, 2018
Notice of Intent to Publish a FOA for Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center (U24) (Clinical Trial Not Allowed) (NOT-AR-19-023)
Estimated Publication Date of FOA: November 21, 2018

October 9, 2018
Notice of Intent to Publish a FOA for Back Pain Consortium (BACPAC) Research Program Technology Research Sites (UH2/UH3) (Clinical Trial Optional) (NOT-AR-19-024)
Estimated Publication Date of FOA: November 21, 2018

October 9, 2018
Notice of Intent to Publish a FOA for Back Pain Consortium (BACPAC) Research Program: Phase 2 Clinical Trials (UG3/UH3) (Clinical Trial Required) (NOT-AR-19-025)
Estimated Publication Date of FOA: November 21, 2018

New Funding Opportunities

Notice Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Not Allowed)
Notice Number RFA-NS-19-010
Earliest Submission Date December 4, 2018
Application Due Date

January 4, 2019 and March 6, 2019, by 5:00 PM local time of applicant organization.

Notice HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (Research Sites) (UM1 - Clinical Trial Required)
Notice Number RFA-DA-19-016
Earliest Submission Date November 11, 2018
Application Due Date

December 11, 2018, by 5:00 PM local time of applicant organization

FAQs HEALing Communities Study Frequently Asked Questions
Notice HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (Data Coordinating Center) (UM1- Clinical Trials Not Allowed)
Notice Number RFA-DA-19-017
Earliest Submission Date November 11, 2018
Application Due Date

December 11, 2018 , by 5:00 PM local time of applicant organization

FAQs HEALing Communities Study Frequently Asked Questions
Notice Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
Notice Number RFA-NS-18-046
Earliest Submission Date October 27, 2018
Application Due Date

November 27, 2018; March 7, 2019; November 25, 2019; March 12, 2020 by 5:00 PM local time of applicant organization

Notice Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
Notice Number RFA-NS-18-043
Earliest Submission Date October 27, 2018
Application Due Date

November 27, 2018; February 11, 2019; July 11, 2019; November 12, 2019, by 5:00 PM local time of applicant organization

Notice Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed)
Notice Number RFA-NS-18-042
Earliest Submission Date October 27, 2018
Application Due Date

November 27, 2018; February 11, 2019; July 11, 2019; November 12, 2019, by 5:00 PM local time of applicant organization

Notice Data Integration and Resource Center (DIRC) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional)
Notice Number RFA-RM-18-031
Earliest Submission Date September 24, 2018
Application Due Date

October 24, 2018, by 5:00 PM local time of applicant organization.

Notice Omics Data Generation Centers (ODGCs) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional)
Notice Number RFA-RM-18-032
Earliest Submission Date September 24, 2018
Application Due Date

October 24, 2018, by 5:00 PM local time of applicant organization.

Notice Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Pain from Musculoskeletal Trauma (UM1 Clinical Trial Optional)
Notice Number RFA-RM-18-033
Earliest Submission Date September 24, 2018
Application Due Date

October 24, 2018, by 5:00 PM local time of applicant organization.

Notice Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain (UM1 Clinical Trial Optional)
Notice Number RFA-RM-18-034
Earliest Submission Date September 24, 2018
Application Due Date

October 24, 2018, by 5:00 PM local time of applicant organization.

Notice Clinical Coordination Center for Common Fund Acute to Chronic Pain Signatures (A2CPS) Program (U24 Clinical Trial Optional)
Notice Number RFA-RM-18-035
Earliest Submission Date September 24, 2018
Application Due Date

October 24, 2018, by 5:00 PM local time of applicant organization.

Notice Administrative Supplements for Validation of Novel Non-Addictive Pain Targets (Clinical Trials Not Allowed)
Notice Number NOT-NS-18-073
Release Date August 23, 2018
Notice Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
Notice Number RFA-NS-18-041
Earliest Submission Date October 27, 2018
Application Due Date

November 27, 2018; March 7, 2019; November 25, 2019; March 12, 2020 by 5:00 PM local time of applicant organization.

Notice NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
ID Number RFA-DA-18-020
Earliest Submission Date June 25, 2018
Application Due Date July 25, 2018; July 25, 2019, July 25, 2020), by 5:00 PM local time of applicant organization.
Notice Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
ID Number RFA-DA-19-002
Application Due Date Rolling basis beginning on January 25, 2018
Notice Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
ID Number PAR-18-219
Application Due Date March 27, 2018; July 25, 2018; March 27, 2019; July 25, 2019, by 5:00 PM local time of applicant organization
Notice Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional)
ID Number PAR-18-218
Application Due Date March 27, 2018; July 25, 2018; March 27, 2019; July 25, 2019, by 5:00 PM local time of applicant organization.

Funded Projects

This page last reviewed on November 13, 2018